Quiz
Phase 3 Data Reveal RSV Vaccine's Efficacy and Safety
Maria Asimopoulos
03/31/2023
The RSVPreF3 OA vaccine is being tested in an ongoing, international, phase 3 trial with participants aged 60 years and older. Researchers recently reported efficacy and safety data.
Subscribe and Stay Ahead With Daily Industry Insights
First Report Managed Care Newsletter